Cargando…
Randomized Control Trial of Postnatal rhIGF-1/rhIGFBP-3 Replacement in Preterm Infants: Post-hoc Analysis of Its Effect on Brain Injury
Background: Postnatal insulin-like growth factor-1 (IGF-1) replacement with recombinant human (rh)IGF-1 and IGF binding protein-3 (rhIGF-1/rhIGFBP-3) is being studied as a potential treatment to reduce comorbidities of prematurity. We have recently reported on a phase II, multicenter, randomized, co...
Autores principales: | Horsch, Sandra, Parodi, Alessandro, Hallberg, Boubou, Malova, Mariya, Björkman-Burtscher, Isabella M., Hansen-Pupp, Ingrid, Marlow, Neil, Beardsall, Kathryn, Dunger, David, van Weissenbruch, Mirjam, Smith, Lois E. H., Hamdani, Mohamed, Mangili, Alexandra, Barton, Norman, Ramenghi, Luca A., Hellström, Ann, Ley, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581737/ https://www.ncbi.nlm.nih.gov/pubmed/33163463 http://dx.doi.org/10.3389/fped.2020.517207 |
Ejemplares similares
-
rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial
por: Ley, David, et al.
Publicado: (2018) -
Assessment of compatibility of rhIGF-1/rhIGFBP-3 with neonatal intravenous medications
por: Salamat-Miller, Nazila, et al.
Publicado: (2022) -
Pilot dose-ranging of rhIGF-1/rhIGFBP-3 in a preterm lamb model of evolving bronchopulmonary dysplasia
por: Albertine, Kurt H., et al.
Publicado: (2023) -
Insulin‐like growth factor 1 has multisystem effects on foetal and preterm infant development
por: Hellström, Ann, et al.
Publicado: (2016) -
rhIGF-1 Therapy: A Silver Bullet for Bronchopulmonary Dysplasia
Prevention?
por: Plosa, Erin J., et al.
Publicado: (2020)